Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Shunsuke Tsuzuki
Institutions:
University of Alabama at Birmingham,
Tokyo Women's Medical University
Observed institutions:
University of Alabama at Birmingham,
Tokyo Women's Medical University,
Institute of Advanced Biomedical Engineering and Science, Tokyo Women's Medical University
ORCID:
0000-0002-8829-3236
Observed ORCID:
0000-0002-8829-3236
OpenAlex ID:
A5070276849
Photodynamic therapy for malignant brain tumors in children and young adolescents
2022
·
Kentaro Chiba
, Yasuo Aihara
, et al.
·
Frontiers in Oncology
·
15
PDF
Increase in serum vimentin levels in patients with glioma and its correlation with prognosis of patients with glioblastoma
2023
·
Taiichi Saito
, Yoshihiro Muragaki
, et al.
·
Neurosurgical Review
·
10
PDF
Cost of medical care for malignant brain tumors at hospitals in the Japan Clinical Oncology Group brain-tumor study group
2024
·
Kazuya Motomura
, Keita Sasaki
, et al.
·
Japanese Journal of Clinical Oncology
·
9
Ncmp-24. Risk Factors of Surgical Site Infection in Glioma Surgery
2022
·
Atsushi Kuwano
, Masayuki Nitta
, et al.
·
Neuro-Oncology
·
1
PDF
Ctni-41. Transition of Long-term Treatment Results of 493 Cases of Newly Diagnosed Glioblastoma and Survival Benefit by Combination With Pdt and Aftv - Aiming to Establish New Standard Treatment
2022
·
Masayuki Nitta
, Yoshihiro Muragaki
, et al.
·
Neuro-Oncology
·
1
PDF
IMMU-19 Tumor-collagen-binding IL-15 superagonist reprograms the immunosuppressive tumor microenvironment in recurrent glioblastoma
2026
·
Shunsuke Tsuzuki
, Pooja Kaur
, et al.
·
Neuro-Oncology
Radiation-Induced Collagen I&III Accumulation Drives Immunosuppressive Evolution in Recurrent Glioblastoma
2026
·
Opeyemi Iwaloye
, Lewis Barr
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
PDF
Clinical and molecular characteristics of thalamic gliomas in adults: prognostic impact of TERT promoter mutation
2026
·
Shunsuke Tsuzuki
, Yoshihiro Muragaki
, et al.
·
Neurosurgical Review
PDF
Tumor-Selective CBD-IL12 Immunotherapy for Recurrent Glioblastoma (Abstract ID: 236152)
2026
·
Opeyemi Iwaloye
, Jun Takei
, et al.
·
Journal of Pharmacology and Experimental Therapeutics
Abstract 7783: Collagen-binding IL-12 remodels immunosuppresive microenvironment and improves survival in recurrent glioblastoma
2026
·
Opeyemi Iwaloye
, Jun Takei
, et al.
·
Cancer Research
Abstract 4045: Collagen binding enhances anti-CTLA4 therapy in recurrent glioblastoma
2026
·
Lewis Barr
, Jun Takei
, et al.
·
Cancer Research
Abstract 5545: Collagen-binding anti-GITR antibody reshapes immunosuppressive microenvironment and prolongs survival in recurrent glioblastoma
2026
·
Jun Takei
, Chuyi Wang
, et al.
·
Cancer Research
EXTH-61. Tumor-matrix binding anti-GITR antibody to overcome recurrent glioblastoma
2025
·
Jun Takei
, Chuyi Wang
, et al.
·
Neuro-Oncology
PDF
DDEL-21. Tumor-collagen binding IL-12 Immunotherapy for recurrent Glioblastoma
2025
·
Opeyemi Iwaloye
, Jun Takei
, et al.
·
Neuro-Oncology
PDF
Association between autologous formalin-fixed tumor vaccine (AFTV) therapy, molecular pathological markers, and survival outcomes in glioblastoma
2025
·
Shunichi Koriyama
, Yoshihiro Muragaki
, et al.
·
Brain Tumor Pathology
PDF
10207- Imt-4 Real-world Data and Immunohistological Study of Autologous Formalin-fixed Tumor Vaccine for Newly Diagnosed Glioblastoma
2024
·
Shunichi Koriyama
, Masayuki Nitta
, et al.
·
Neuro-Oncology Advances
“Apathetic look” is a valuable indicator of intraoperative supplementary motor area syndrome during awake craniotomy
2024
·
Taiichi Saito
, Yoshihiro Muragaki
, et al.
·
Neurosurgical Review
Stmo-17 Usefulness of Integration of Preoperative Functional Imaging and Intraoperative Mri Navigation System in Glioma Surgery
2022
·
Manabu Tamura
, Ikuma Sato
, et al.
·
Neuro-Oncology Advances
PDF
Act-24 Long Term Clinical Results of Newly Diagnosed Glioblastoma by Age and Treatment Strategy
2022
·
Masayuki Nitta
, Yoshihiro Muragaki
, et al.
·
Neuro-Oncology Advances
PDF
Rt-7 Differentiation and Treatment of Recurrence and Radiation Necrosis in the Treatment of Malignant Gliomas
2022
·
Shunsuke Tsuzuki
, Masayuki Nitta
, et al.
·
Neuro-Oncology Advances
Show more works
View as search
Works count:
20
Citation count:
36
H-index:
3
I10-index:
2
Year
Topic
Type